6,6-DIFLUORO-11,17-DIHYDROXY-16-METHYL-21-(3-(METHYLSULFINYL)-1-OXOPROPOXY)-PREGNA-1,4-DIENE-3,20-DIONE, (11.BETA.,16.ALPHA.)-
UNII B6238JC34W
Substance Identification & Data
This profile provides standardized clinical and technical data for 6,6-difluoro-11,17-dihydroxy-16-methyl-21-(3-(methylsulfinyl)-1-oxopropoxy)-pregna-1,4-diene-3,20-dione, (11.beta.,16.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B6238JC34W.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 37695-39-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H34F2O7S YKDURBMVIXHCBC-INXSOENXSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6,6-difluoro-11,17-dihydroxy-16-methyl-21-(3-(methylsulfinyl)-1-oxopropoxy)-pregna-1,4-diene-3,20-dione, (11.beta.,16.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.